In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BioVentrix brings in $7mm through late-stage venture round

Executive Summary

BioVentrix Inc. (cardiovascular device company that is also doing business as CHF Technologies Inc.) has raised $7mm through a late-stage venture round, possibly its Series G financing. There were eight undisclosed investors. The company has developed the Revivent myocardial anchoring system to reduce enlarged left ventricles in patients with heart failure.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies